glp 1 agonist in ckd Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis 🔴GLP-1 receptor agonists in patients

doi: 10.1111/j.1463-1326.2012.01557.x 159 AnvariMPatersonCADanielEEMcDonaldTJ

We have moved far beyond simple glycemic control

Glucagon Receptor The first description of the hyperglycemic effects of glucagon was made more than a century ago [25, 26]

By delaying stomach emptying and increasing feelings of fullness, they help people eat less and, over time, lose significant weight

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

Two interventions have a strong evidence base and should, in my view, be part of every GLP-1 treatment discussion